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Activation of the basal ganglia has been shown during the preparation and
execution of movement. However, the functional interaction of cortical and subcortical
brain areas during movement and the relative contribution of dopaminergic striatal
innervation remains unclear. We recorded local field potential (LFP) activity from the
subthalamic nucleus (STN) and high-density electroencephalography (EEG) signals
in four patients with Parkinson’s disease (PD) off dopaminergic medication during
a multi-joint motor task performed with their dominant and non-dominant hand.
Recordings were performed by means of a fully-implantable deep brain stimulation
(DBS) device at 4 months after surgery. Three patients also performed a single-photon
computed tomography (SPECT) with [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-
iodophenyl)nortropane (FP-CIT) to assess striatal dopaminergic innervation. Unilateral
movement execution led to event-related desynchronization (ERD) followed by a
rebound after movement termination event-related synchronization (ERS) of oscillatory
beta activity in the STN and primary sensorimotor cortex of both hemispheres.
Dopamine deficiency directly influenced movement-related beta-modulation, with
greater beta-suppression in the most dopamine-depleted hemisphere for both ipsi-
and contralateral hand movements. Cortical-subcortical, but not interhemispheric
subcortical coherencies were modulated by movement and influenced by striatal
dopaminergic innervation, being stronger in the most dopamine-depleted hemisphere.
The data are consistent with a role of dopamine in shielding subcortical structures
from an excessive cortical entrapment and cross-hemispheric coupling, thus allowing
fine-tuning of movement.
Keywords: beta oscillations, motor control, movement disorders, imaging, Parkinson’s disease, subthalamic
nucleus, coherence analysis
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INTRODUCTION
The functional interaction of cortical and subcortical brain areas
during movement planning and execution, and in particular
the role of striatal dopaminergic innervation, remains unclear.
Subjects with Parkinson’s disease (PD) may represent a putative
in vivo model of dopaminergic denervation (Simuni and Pahwa,
2009) and, when implanted with subthalamic nucleus deep
brain stimulation (STN-DBS), can provide the remarkable
opportunity to investigate cortical-subcortical interactions by
simultaneous recording of local field potential (LFP) and high
density electroencephalography (EEG).
STN recordings reveal that when at rest, unmedicated PD
patients show an excessively synchronized neuronal activity in
the STN and an exaggerated coupling between the STN and
the motor cortices (MC). This abnormal activity and coupling
is particularly strong in the beta frequency range (≈13–35 Hz)
and is reduced by dopaminergic drugs or STN-DBS (Williams
et al., 2002; Fogelson et al., 2006; Doyle Gaynor et al., 2008;
Kühn et al., 2008; de Solages et al., 2010; Giannicola et al.,
2010; Litvak et al., 2011a, 2012; Hirschmann et al., 2013;
Kato et al., 2015; Quinn et al., 2015; Weiss et al., 2015;
Oswal et al., 2016) and modulated by voluntary movements
(Marsden et al., 2001; Cassidy et al., 2002; Lalo et al., 2008;
Hirschmann et al., 2013). In particular, movement execution and
imagination are associated with beta power changes (Cassidy
et al., 2002; Kühn et al., 2004), starting with a decrease
or desynchronization in the pre-movement period (event-
related desynchronization, ERD) followed by a rebound after
movement termination (event-related synchronization, ERS;
Cassidy et al., 2002). A similar dynamic pattern of movement-
related beta modulation is also present at the cortical level
with a morphology that does not substantially differ from that
recorded from control subjects (Soikkeli et al., 1991; Alegre
et al., 2005; Devos et al., 2006; Meziane et al., 2015; Moisello
et al., 2015). Moreover, excessive cortical beta power at rest
has been recently correlated with greater movement-related
beta-modulation and motor performances (Heinrichs-Graham
and Wilson, 2016).
It is likely that striatal dopamine loss is the main cause
of abnormal STN activity and cortical-subcortical dynamics
in PD (for review, Jenkinson and Brown, 2011; Brittain and
Brown, 2014), but direct evidence for this hypothesis is still
lacking. We envision a role for dopamine in shielding subcortical
structures from excessive cortical drive (Jenkinson and Brown,
2011; Oswal et al., 2013), thus allowing the correct set up of
motor programs required for subsequent motor action (Wilson,
Abbreviations: BPND, non-displaceable binding potential; DAT, dopamine
reuptake transporter; DBS, deep brain stimulation; ERD, event-related
desynchronization; ERS, event-related synchronization; FP-CIT, [123I]N-ω-
fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane; ICA, independent
component analysis; iCoh, imaginary part of the coherency; LEDD, levodopa
equivalent daily dose; LFPs, local field potentials; MC, Motor cortices;
MT, movement time; OT, onset time; PA, peak acceleration; PL, path length;
PV, peak velocity; ROI, region of interest; RT, return time; SPECT, single-
photon computed tomography; STN, Subthalamic Nucleus; UPDRS-III, Unified
Parkinson Disease Rating Scale motor part; VOI, volume of interest.
2014). A lack of striatal dopaminergic tone, as in patients with
PD, would therefore facilitate the basal ganglia entrainment
in excessively synchronized oscillatory activity, thus impairing
the processing of motor commands (Jenkinson and Brown,
2011; Wilson, 2014). To further elucidate the role of dopamine
in cortical-basal ganglia motor processing, we measured beta
ERD and ERS, subcortical and cortical-subcortical coherency
in patients with PD during a multi-joint, externally-triggered
motor task performed with the dominant and non-dominant
hand.
Importantly, we determined the level of dopaminergic striatal
innervation with a [123I]N-ω-fluoropropyl-2β-carbomethoxy-
3β-(4-iodophenyl)nortropane (FP-CIT) and single-photon
computed tomography (SPECT; Isaias et al., 2010, 2011). Also of
relevance, in this study we used an investigational DBS device
(Activa PC+Sr, Medtronic, PLC) that offers the possibility of




We tested seven right-handed patients with PD (6 males,
1 female; median age 61 years [range: 67–53 years]; median
disease duration 11 years [range: 10–19 years]). All patients
were diagnosed according to the UK Parkinson Disease
Brain Bank criteria (Hughes et al., 2002) and evaluated
with the Unified Parkinson Disease Rating Scale motor part
(UPDRS-III). All subjects were right-handed as assessed by
a modified Edinburgh handedness inventory. Patients were
implanted at the University Hospital of Würzburg between
December 2013 and May 2014 with the Activa PC+Sr
neurostimulation system (Medtronic, PLC). This system allows
therapeutic DBS as well as on-demand LFP recordings from
the implanted STN electrodes (Rouse et al., 2011; Stanslaski
et al., 2012). The Activa PC+Sr system and the related hardware
and software for programming and readout were provided
under a request for application agreement by Medtronic,
PLC. The company had no impact on study design, patient
selection, data analysis, or reporting of the results. All patients
had been selected based on established criteria for DBS
surgery (Pollak, 2013). Of relevance, none of the subject had
cognitive decline or mood disturbances as evaluated using the
Parkinson neuropsychometric dementia assessment (PANDA),
Mattis Dementia Rating Scale (MDRS), Hamilton Depression
Rating Scale (HDRS) and the Non-Motor Symptoms Scale
(NMSS).
The surgical procedure has been described elsewhere
(Steigerwald et al., 2008). In brief, implantation was performed
under local anesthesia using Leksell’s Frame (Elekta, Leksell
Stereotaxy System, Stockholm, Sweden). The DBS electrode used
was model 3389 (Medtronic, PLC) with four platinum–iridium
cylindrical contacts of 1.5 mm each and a contact-to-contact
separation of 0.5 mm. Contact 0/8 was the lowermost and
contact 3/11 the uppermost (E0–3 refers to right- and
E8–11 to the left-hemisphere). The intended coordinates for
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STN were 12 mm lateral, 2 mm posterior, 4 mm ventral to
the mid-commissural point and were adjusted according to
individual STN delineation on T2-weighted and SWI images
(Magnetom Trio, Siemens Healthcare, Erlangen, Germany)
and with intraoperative microelectrode recordings. Micro- and
macro-electrode stimulation and intraoperative CT scan also
served to confirm targeting. Postoperative scanning (1 mm slice-
thickness, CT scan fusion with the pre-operativeMRI) confirmed
electrode location. Of note, the presence or absence of LFP power
in the beta band was not used to determine the placement of the
DBS lead (Quinn et al., 2015).
The precise localization within the STN of the active
contacts used for chronic stimulation was further confirmed
by image fusion of a non-stereotactic postoperative CT with
the preoperative planning MRI by means of Optiviser software
under a research agreement with Medtronic, PLC. Correct
placement of the DBS electrode was also verified by the
clinical response to DBS (meds-off/stim-on) compared to
the preoperative improvement of the UPDRS motor score
(UPDRS-III) during levodopa challenge (meds-off vs. meds-
on; Table 1). Therapeutic response to DBS or levodopa was
expressed as percentage of improvement, according to the
formula: ((a—b)/a) × 100 (adapted from Isaias et al., 2008)
where a = meds-off UPDRS-III score and b = meds-on
UPDRS-III at pre-DBS or b = meds-off/stim-on UPDRS-III
at the time of the test, 4 months after surgery (post-DBS).
The mean percentage of improvement was 65.77% (range:
42.5%–92.72%) due to dopaminergic medication and 68.82%
(range: 52.5%–83.63%) due to STN stimulation, thus further
supporting correct placement of the DBS electrodes.
Demographic and clinical information for all subjects is listed
in Table 1. At the time of this study, all patients were on stable
TABLE 1A | Sample characteristics.















wue2∗ male 65 10 1100 40 23 800 19
wue3 male 61 18 2725 40 9 600 13
wue5∗ male 67 17 1050 49 24 500 13
wue6 male 51 11 1133 47 12 180 9
wue7 male 61 10 650 43 24 220 19
wue9∗ male 55 19 1200 50 11 730 16
wue11∗ female 53 11 1300 55 4 460 9
Demographic and clinical information. Before surgery participants were tested after overnight withdrawal of all dopaminergic medications (meds-off). To evaluate the effect
of levodopa (meds-on), the patient had turned into a good quality “on-state” upon receiving 1–1.5-times the levodopa-equivalent of the preoperative morning dose. After
surgery, all patients were evaluated in meds-off condition but under chronically effective STN stimulation (meds-off, stim-on). ∗ Indicates the four patients (i.e., wue2, 5,
9 and 11) who were able to complete the motor task (i.e., with both hands in the required amount of time, please refer to “Task and Experimental Design” in the “Materials
and Methods Section”). DBS, deep brain stimulation; LEDD, levodopa equivalent daily dose; STN, subthalamic nucleus; UPDRS-III, Unified Parkinson Disease Rating
Scale motor part.
TABLE 1B | Molecular imaging data.
Subject Percentage loss of DAT binding STN− AI Striatum
Putamen right Putamen left Caudate n. right Caudate n. left Striatum right Striatum left
wue2∗ 57.87 73.61 43.48 65.22 47.53 67.71 L 47.62
wue3 87.04 85.65 87.75 80.63 86.55 82.06 R 28.57
wue5∗ - - - - - - R§ -
wue6 57.87 72.69 38.34 48.22 46.19 57.40 L 23.26
wue7 63.43 70.37 51.78 63.64 55.16 65.92 L 27.27
wue9∗ 82.87 77.78 75.49 71.54 78.03 72.65 R 21.82
wue11∗ 65.74 63.43 44.27 54.55 52.91 56.95 L 8.96
Percentage loss of DAT binding values calculated with respect to a group of 15 healthy subjects (see Table S1). The DAT binding values of the striatum were used to
identify the relative STN− and MC− or STN+ and MC+. We used the whole striatum, rather than its motor part (i.e., the putamen), as the boundaries between the
putamen and the caudate nucleus are uncertain in SPECT images. One subject (i.e., wue5) was not willing to perform a SPECT, and STN− or MC− and STN+ or MC+
were based on UPDRS-III score as indicated by §. The clinically most affected hand (higher UPDRS scores) always corresponded to the striatum with less nigro-striatal
dopaminergic innervation. The AI was calculated as the relative change of BPND (see Table S1): AI = ((BPND striatum ipsilateral − BPND striatum contralateral)/(BPND
striatum ipsilateral + BPND striatum contralateral)) x 200. In this case, contralateral refers to the side opposite to the clinically most affected hemibody. For healthy subjects,
we considered the average striatal binding of left and right, which did not significantly differ in all subjects. AI, asymmetry index; DAT, dopamine reuptake transporter;
BPND, non-displaceable binding potential; L, left; MC, motor cortex; R, right; SPECT, single-photon computed tomography; STN, subthalamic nucleus; UPDRS-III, Unified
Parkinson Disease Rating Scale motor part. ∗ Indicates the four patients (i.e., wue2, 5, 9 and 11) who were able to complete the motor task (i.e., with both hands in the
required amount of time, please refer to “Task and Experimental Design” in the “Materials and Methods Section”).
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TABLE 1C | Clinical data.
wue2 wue5 wue9 wue11
UPDRS-III meds-off Total hemibody-score right 20 13 12 22
Total hemibody-score left 10 19 22 13
Tremor subscore right 4 0 0 0
Tremor subscore left 0 1 1 0
Rigidity-bradykinesia subscore right 16 13 12 22
Rigidity-bradykinesia subscore left 10 18 21 13
UPDRS-III meds-on Total hemibody-score right 13 10 0 1
Total hemibody-score left 4 9 7 0
Tremor subscore right 3 0 0 0
Tremor subscore left 0 0 0 0
Rigidity-bradykinesia subscore right 10 10 0 1
Rigidity-bradykinesia subscore left 4 9 7 0
UPDRS-III subscores of the four subjects who completed the study protocol. We found a strong lateralization of clinical symptoms. In meds-off condition, the median
UPDRS-III score of the most and least affected hemibodies were 22 (range 19–22) and 12 (range 10–13) respectively. UPDRS-III, Unified Parkinson Disease Rating Scale
motor part.
dopaminergic treatment (for at least 2 months) and chronically
stimulated for 4 months (at least 1 month with unchanged DBS
stimulation parameters). The local institutional review board of
the University Hospital Wuerzburg approved the study and all
patients gave written informed consent.
SPECT Data Acquisition and
Reconstruction
SPECT data acquisition, reconstruction (Lapa et al., 2015) and
analysis has been described in detail previously (Isaias et al., 2010,
2011). All patients but one (i.e., wue5) were willing to perform a
SPECT with FP-CIT to measure dopamine reuptake transporter
(DAT) density. SPECTs were performed within 3 months
before surgery. Scans were started 180 min after injection of
182.3 ± 3.6 MBq of FP-CIT on a dual-headed integrated
SPECT/CT system (Symbia T2; Siemens, Erlangen, Germany)
in the meds-on condition. In brief, SPECT data were spatially
normalized onto a FP-CIT MNI-based template and volumes of
interest (VOI) of caudate nucleus, putamen and striatum (for
both hemispheres), as well as a reference region in the occipital
cortex, were defined using the automated anatomical labeling
(Tzourio-Mazoyer et al., 2002). The non-displaceable binding
potential (BPND) was then assessed using average regional uptake
values fromVOI analysis and the occipital cortex as the reference
region (Innis et al., 2007). The asymmetry index (AI, expressed as
a percent) of whole striatal DAT availability was calculated as the
BPND difference (Striatumipsilateral−Striatumcontralateral) relative
to the mean value of both striatum.
Striatal DAT binding measurements for each patient were
compared with normal values of 15 healthy subjects (4 males,
11 females, age range: 44–68 years; Table S1, Supplementary
Material). The striatal dopaminergic loss exceeded 50%
bilaterally in all but one subject (i.e., wue2, left striatum:
67.7% and right striatum: 47.5%). As previously reported
(Panzacchi et al., 2008), the clinically most affected hand (higher
UPDRS-III scores) always corresponded to the striatum with
less nigro-striatal dopaminergic innervation. The percentage loss
of DAT binding values is listed in Table 1 section B. The most
affected side was the right one in two out of the four patients
who completed the whole study protocol. Based on molecular
imaging and clinical data, we identified the hemisphere with less
(STN− and motor cortex, MC−) or more (STN+ and MC+)
dopaminergic innervation.
Task and Experimental Design
The motor tasks have been extensively described in previous
studies (Ghilardi et al., 2000; Perfetti et al., 2010; Isaias et al., 2011;
Moisello et al., 2015). Briefly, subjects performed a single, multi-
joint, uncorrected movement, as accurate and as fast as possible
(Figure S1, Supplementary Material). They moved a cursor with
either their dominant (right) or non-dominant (left) hand on a
digitizing tablet, straight out-and-back, from a central starting
point to one of eight equidistant (4 cm) radially-arranged targets
that appeared on a screen. An opaque panel prevented the arm
vision. All targets were displayed on a screen as circles (2 cm
diameter). Targets were presented in random order every 3 s in
three blocks of 16 movements each. Participants were tested in
meds-off/stim-off condition (i.e., after overnight withdrawal of
all dopaminergic drugs and after pausing DBS for at least 1 h)
andwere asked to perform the task first with the dominant (right)
hand and then with the non-dominant (left) hand, irrespective of
the more affected body side.
A neurologist (IUI) supervised the absence of any mirror
movement or tremor in the hand not performing the task. The
data presented refer only to the four subjects who completed the
whole study protocol. Three patients were not able to complete
the task in the required amount of time (i.e., 3 s per movement)
with the right or left hand, and therefore their data were excluded
from the analyses.
Data Recordings and Analysis
For each movement, we measured: onset time (OT, time from
target appearance to movement onset), movement time (MT,
time from movement onset to reversal), peak velocity (PV)
and peak acceleration (PA) and path length (PL, from onset to
reversal).
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LFPs were recorded with a single bipolar contact
configuration for each STN and amplified by 1000. The
recording contacts were chosen according to the chronic
stimulation setting as a bipolar montage of the two contacts
surrounding the stimulation cathode (Devos et al., 2006;
Quinn et al., 2015). High density EEG (hdEEG) signals were
acquired with a 128-channel EEG Brainamp system (BrainAmp
ExG, Brain Product) with sampling frequency at 1000 Hz.
LFP and hdEEG recordings were synchronized by means
of a common external signal (Figure S2, Supplementary
Material), re-sampled at 250 Hz, bandpass filtered in the
range 0.5–80 Hz and segmented into 6 s epochs based on the
movement onset latencies from −4 s to 2 s after the return-
time (RT). RT equals the time point in which the subject
came back to the central target (Figure S1, Supplementary
Material).
The hdEEG channels affected by bad scalp-electrode
were visually identified and replaced with spherical spline
interpolation. Trials with sporadic artifacts were excluded by
visual inspection. Stereotypical artifacts (e.g., blinks, heartbeat,
and muscle tension) were removed by independent component
analysis (ICA; Jung et al., 2000; Onton and Makeig, 2006; Onton
et al., 2006). For LFPs artifacts management, please refer to the
supplementary material (Figure S3). LFP and hdEEG signals
were processed and analyzed by means of MatLab-based custom
script, EEGLAB (Delorme and Makeig, 2004), Brainstorm
(Tadel et al., 2011) and SPM M/EEG Toolbox (Litvak et al.,
2011b).
We then calculated the event-related power relative changes
(ERD and ERS), normalizing the mean beta power by
subtracting and dividing the average power of the whole task
interval (from −3 s to 0 s) relative to the RT, multiplied
by 100. For efficient spectral estimation of the relatively
small number of trials, we used multitaper spectral analysis
(Thomson, 1982). We estimated the spectra between −4 s
and 2 s relative to the RT of each trial, in overlapping
windows of 400 ms with a time resolution of 50 ms.
The time-frequency bandwidth was set to 1.5, resulting in
two tapers being used. The time-frequency images were
then averaged using robust averaging (Wager et al., 2005;
Holland and Welsch, 2007; Litvak et al., 2012) and the
event-related power changes were obtained by normalizing to
the whole trial (−3 s to 0 s) before RT. A representative
time-frequency plot showing the cortical and subcortical ERD
and ERS is shown in Figure S4 (Supplementary Materials,
Methods).
To study cortical beta variations, we assessed the rebound in
the beta band (13–35 Hz). The beta-rebound is the largest peak-
to-peak difference between the minimum of the ERD during
movement and the maximum of the post-movement ERS in
beta band calculated, respectively, between −2 s and −1 s, and
between 0 s and 1 s after RT.
Topological maps of these parameters showed two main
clusters around CCP3h and CCP4h, as described also in previous
studies (Alegre et al., 2005; Meziane et al., 2015; Moisello et al.,
2015). Accordingly, we defined two region of interest (ROI) of
eight electrodes surrounding CCP3h and CCP4h respectively.
The selected electrodes predominantly represent activity over the
primary sensorimotor cortex, being the supplementary motor
area more medially and the premotor cortex more frontally
located (Lalo et al., 2008).
To study the functional connectivity between cortical and
subcortical structures, we then computed the coherency between
the LFP signals of both the STN and the aforementioned
cortical areas (Friston, 2011). We adopted the same method
used for spectral estimation for the estimation of coherency. In
this case, we also performed a robust averaging (Litvak et al.,
2012). Finally, we computed the absolute value of the coherency
(i.e., the coherence Coh) and the imaginary part of the coherency
(iCoh) to isolate the part of coherency possibly affected by
volume conduction (Nolte et al., 2004, 2008; Hohlefeld et al.,
2013).
General Statistical Analysis
Statistical significance of the behavioral performances was
assessed by means of a two sample unpaired t-Test with a
significance level p< 0.05.
Beta ERD and ERS were calculated computing the mean beta
event-related power changes and then the mean beta rebound
values for each subject. We assessed significant differences
for all the six possible comparisons: −CONTRA vs. +CONTRA;
−IPSI vs. +IPSI; −CONTRA vs. +IPSI; −IPSI vs. +CONTRA; −IPSI vs.
−CONTRA; +IPSI vs. +CONTRA. We used a permutation test for
each time point of the beta event-related power changes (with
Bonferroni correction for multiple comparisons) and for the beta
rebound values. For each comparison (e.g., STN−CONTRA vs.
STN+CONTRA), we computed the observed statistic (Tobs) as the
difference between the event-related power changes or between
the rebound, respectively. For constructing the surrogates (Tsurr),
we shuffled the trials of each of above listed comparisons
(separately), we then recomputed the surrogated event-related
power changes and the surrogated beta rebound values. We
performed the shuffling 10,000 times with replacement obtaining
10,000 Tsurr values for each test. The p value was computed
as the Pr{Tsurr > Tobs}. The significance level was set at
p< 0.05.
Significant regions of Coh and iCoh were determined by
statistical comparison to a population of 50 surrogate Coh maps
in which any coherence was destroyed. For each pair of channels,
the surrogates Coh were generated shuffling the order of trials in
one of the two channels. The significance level was set at p< 0.05.
Multiple comparisons were corrected with false discovery rate




Movement of the most-affected hand showed a longer MT and
lower PV and PA with respect to the less affected hand, though
not statistically significant (Table 2). These differences were also
present when comparing the movement of the non-dominant vs.
dominant hand (Table 2).
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TABLE 2 | Behavioral data.
Least-affected Most-affected Dominant (right) Non-dominant (left)
OT (ms) 460 (304–693)∗ 412 (281–600)∗ 437 (300–675) 435 (289–626)
MT (ms) 725 (378–1092) 766 (425–1273) 699 (383–1074)• 792 (413–1278)•
PV (cm/s) 8.13 (4.25–15.11) 7.79 (3.76–14.93) 8.34 (4.47–15.01)∆ 7.58 (3.74–15.06)∆
PA (cm/s2) 104.09 (32.94–265.65) 103.59 (30.98–275.01) 110.03 (32.52–287.88)§ 97.65 (31.69–251.81)§
PL (cm) 4.82 (3.79–5.92)♦ 5.08 (3.91–6.75)♦ 5.17 (4.12–6.75)# 4.73 (3.72–5.77)#
RT (s) 2.04 (1.41–2.78) 2.08 (1.48–2.89) 2.03 (1.4–2.77) 2.05 (1.47–2.87)
In all patients, the most-affected side was contralateral to the striatum with less DAT binding values. All subjects were right-handed, as assessed by a modified Edinburgh
handedness inventory. DAT, dopamine reuptake transporter, OT, onset time (time from target appearance to movement onset); MT, movement time (time from movement
onset to reversal); PV, peak velocity; PA, peak acceleration; PL, path length (from onset to reversal); RT, return time (the time needed to come back to the central target).
Values are expressed as median and range. Statistical significance was assessed by means of a two sample unpaired t-Test, §p < 0.05 and ∗,♦,•,∆,# p < 0.01.
Subthalamic Nucleus and Cortical
Recordings
The most striking finding of this study was the stronger
β-modulation in the STN of the most dopamine-depleted
hemisphere (Figure 1A). Compared to STN+, the STN−
(i.e., the one in the hemisphere with less striatal dopaminergic
innervation) exhibited greater beta-modulation, both stronger
beta-reduction and a higher post-movement rebound, during
contralateral hand movements (i.e., the clinically most affected
side) and, although weaker, also during ipsilateral hand
movements (Tables 3, 4). Beta-modulation in STN+ instead
did not significantly differ according to the moving side
(Figure 1A; Table 4, subject by subject comparisons are shown
in Figure S6A).
At a cortical level, MC+ and MC− showed a similar temporal
evolution of beta-power, with a steep beta reduction followed
by an increase after movement end (Figure 1A). Similar to
STN−, the MC− exhibited a more pronounced ERD and ERS
for contralateral movements compared to ipsilateral ones. Such
a difference was not found in MC+, where movements of both
hands evoked similar responses (Table 4, subject by subject
comparisons are shown in Figure S6B).
Of note, in one patient with relatively preserved right striatal
dopaminergic innervation (<50% loss; i.e., wue2), we showed
the smallest beta modulation in the corresponding cortical
and subcortical areas (i.e., MC+ and STN+), whereas the
patient with the greatest striatal dopaminergic innervation loss
(>70%, bilaterally; i.e., wue9) showed the strongest bilateral beta
modulation (Figure 1B).
When grouping the data by handedness, we found a similar
time evolution of beta-power between the twoMC (i.e., MCL and
MCR) and of the two STN (i.e., STNL and STNR), regardless of
the moving hand (Figure 1C).
Cortical-subcortical (i.e., CohMC−/STN−, CohMC+/STN−
and CohMC−/STN+, CohMC+/STN+) and subcortical
(i.e., CohSTN−/STN+) coherences are shown in Figure 2.
Each patient displayed a distinctive frequency of coherence
within the beta range. Cortical-subcortical coherencies
diminished during movement execution (i.e., from −2 s
to 0 s). In all patients, CohMC−/STN− was greater than
CohMC+/STN− and CohMC+/STN+ irrespective of the
moving hand. Of note, the patient with the greatest
striatal DAT loss (i.e., wue9) showed the most persisting
and strongest cortical-subcortical coherences, also in
the MC+ hemisphere (Figure 2, Supplementary Figures
S7,S8).
We also found a significant subcortical, cross-hemispheric
coupling (i.e., CohSTN−/STN+), although weaker than the
ipsilateral cortical-subcortical ones. This subcortical coherence
was not affected by movement (Figure 2) and mirrored the
cortical-subcortical coherence, being higher in the patient with
the greatest bilateral striatal DAT loss (i.e., wue9; Figure 2,
Supplementary Figures S7, S8).
DISCUSSION
Our findings suggest that movement-related beta-modulation is
dependent on striatal dopaminergic innervation. Specifically, we
described greater modulation of STN activity in the hemisphere
with less dopaminergic innervation in three subjects with PD
and STN-DBS, in particular for movements performed with
contralateral hand (Figure 1).
These data provide preliminary evidence of a role of striatal
dopamine for precise cortical-subcortical tuning of movement,
and distinctive cortical-basal ganglia motor processing of ipsi-
and contralateral movements (Devos et al., 2006). In line with our
findings, several studies reported excessive beta oscillations in the
STN of PD patients, which was reduced by voluntary movements
(for review, Hammond et al., 2007; Brittain and Brown, 2014).
One study, with self-initiated left and right wrist extensions
in alternating series, also showed greater STN beta-modulation
in the most affected body side of PD patients (Alegre et al.,
2005).
Coherency analyses, a measurement of functional
connectivity (Friston, 2011), can serve to study the cortical-
basal ganglia network organization. Indeed, the functional
segregation among cortical-basal ganglia loops might rely
on distinct anatomical connections, but also be frequency-
dependent through the coupling of precise activities at specific
frequency bands (Fogelson et al., 2006; Lalo et al., 2008). We
can further assume that cortical-subcortical (beta-) coherency
reflects the number of coupled neurons (Marsden et al., 2001;
Cassidy et al., 2002; Lalo et al., 2008). Most of the studies
addressing coherency of cortical-basal ganglia circuitry were
performed at rest (Williams et al., 2002; Fogelson et al., 2006;
Hirschmann et al., 2011; Litvak et al., 2011a; Kato et al., 2015).
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FIGURE 1 | Beta-rebound and striatal dopaminergic denervation. (A) Movement-related beta-modulation with respect to the more and less
dopamine-depleted hemisphere. The blue lines represent the movement performed with the hand contralateral to the examined brain structure, red lines with the
ipsilateral one. Solid lines represent the average across subjects and thin lines the beta-modulation of each subject. The super-imposed vertical dotted line at 0 s
shows the return time (RT). We also indicated with a dotted line at −1.7 s the mean onset time (OT) of all trials (see also Figure S1), as a rough indication of
movement OT. (B) Movement-related beta-modulation for each subject across all valid trials and the corresponding
[123 I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane (FP-CIT) and single-photon computed tomography (SPECT) images. (C) Movement-related
power change in left and right (MCL and MCR) and subthalamic nucleus (STNL and STNR). The yellow lines represent the movement performed with the dominant
hand, the green lines with the non-dominant one. Solid lines represent the average across subjects and thin lines the beta-modulation of each subject. Values are
reported in Table 4.
These studies described an excessive subcortical- and cortical-
subcortical coupling in subjects with PD in meds-off state
(Williams et al., 2002; Fogelson et al., 2006; Hirschmann et al.,
2011; Litvak et al., 2011a; Kato et al., 2015). Two studies also
investigated the effect of levodopa and voluntary movements,
but with inconsistent results (Lalo et al., 2008; Hirschmann
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TABLE 3 | Beta-oscillation power analyses.
β-power raw data wue2 wue5 wue9 wue11
IPSI CONTRA IPSI CONTRA IPSI CONTRA IPSI CONTRA
STN− (mV2) 4.48e-02 4.98e-02 3.27e-02 3.46e-02 18.8e-02 18.2e-02 9.08e-02 8.57e-02
STN+ (mV2) 1.19e-02 1.17e-02 3.38e-02 3.40e-02 1.82e-02 1.69e-02 2.73e-02 2.50e-02
STN− (-dB) 73.48 73.02 74.85 74.61 67.26 67.40 70.41 70.67
STN+ (-dB) 79.24 79.33 74.71 74.68 77.40 77.71 75.63 76.01
Spectral power of the neuronal oscillations in the beta frequency range (13–35 Hz) was computed in each subject who completed the study protocol for both the STN
and task (i.e., movement with the right and left hand). “IPSI” and “CONTRA” refer to movement performed with the hand ipsilateral or contralateral to the examined STN
(STN− or STN+). “−” (MC− and STN−) and “+” (MC+ and STN+) refer instead to the side with less and more striatal dopaminergic innervation or the more and less
clinically affected hemibody (for wue05). MC, motor cortex; STN, subthalamic nucleus.
TABLE 4 | Beta-rebound measurements.
A STN− STN+ STN− STN+ STN− STN+ STN− STN+ STN− STN− STN+ STN+
CONTRA CONTRA IPSI IPSI CONTRA IPSI IPSI CONTRA IPSI CONTRA IPSI CONTRA
wue02 49.94 17.62∗ 43.95 17.33∗ 49.94 17.33∗ 43.95 17.62∗ 43.95 49.94 17.33 17.62
wue05 51.74 16.90∗ 25.40 19.19 51.74 19.19∗ 25.40 16.90 25.40 51.74∗ 19.19 16.90
wue09 64.74 36.20∗ 48.51 29.74∗ 64.74 29.74∗ 48.51 36.20∗ 48.51 36.20∗ 29.74 36.20
wue11 63.93 31.75∗ 37.01 38.57 63.93 38.57∗ 37.01 31.75 37.01 63.93∗ 38.57 31.75
B MC− MC+ MC− MC+ MC− MC+ MC− MC+ MC− MC− MC+ MC+
CONTRA CONTRA IPSI IPSI CONTRA IPSI IPSI CONTRA IPSI CONTRA IPSI CONTRA
wue02 32.45 26.84 19.67 22.64 32.45 22.64 19.67 26.84 19.67 32.45∗ 22.64 26.84
wue05 55.88 57.13 42.54 63.77∗ 55.88 63.77 42.54 57.13 42.54 55.88 63.77 57.13
wue09 56.76 59.31 31.75 57.39∗ 56.76 57.39 31.75 59.31∗ 31.75 56.76∗ 57.39 59.31
wue11 60.57 34.75∗ 36.03 63.80∗ 60.57 63.80 36.03 34.75 36.03 60.57∗ 63.80 34.75∗
Significant differences considering separately the STN (A) and the MC (B) for all the six possible comparisons. Brain structures are distinguished with regards to striatal
dopaminergic innervation loss and clinical severity. In each cell, we show the average rebound value, expressed as percentage of relative power change (see also
Figure 1 and Figure S6, Supplementary Material, Results). As in Table 3, “IPSI” and “CONTRA” refer to movement performed with the hand ipsilateral or contralateral to
the examined STN (STN− or STN+). “−” (MC− and STN−) and “+” (MC+ and STN+) refer instead to the side with less and more striatal dopaminergic innervation or the
more and less clinically affected hemibody (for wue05). MC, motor cortex; STN, subthalamic nucleus. ∗ Indicates significance at p < 0.05 between each comparison (e.g.,
STN−CONTRA vs. STN+CONTRA).
et al., 2013). In particular, Lalo et al. (2008) described a
movement-related drop of cortical-subcortical coupled beta-
activity, possibly driven by the cortex, during a repetitive hand
flexion-extension task. In this study, coherencies were not
influenced by levodopa. On the contrary, Hirschmann et al.
(2013) reported a significant reduction of cortical-subcortical
coupling after levodopa intake during the execution of a
simple motor task, that is opening-closing hand. In all but one
patient (i.e., wue11) in our study, cortical-subcortical coherence
was greatly diminished during movements and reappeared
in rest intervals, predominantly in the hemisphere with less
striatal dopaminergic innervation (i.e., STN− and MC−;
Figure 2). Anecdotally, the patient with the strongest cortical-
subcortical coherence also in the less affected hemisphere
(i.e., CohMC+/STN+; i.e., wue9) showed the greatest bilateral
loss of striatal dopamine (also in the less affected striatum [left
side]: 72.65%, Table 1). In line, CohMC+/STN+ were absent
in the two patients with overall higher DAT bindings values
(i.e., wue2 and wue11; Table 1). Taken together, these data
suggest a direct influence of striatal dopamine on cortical-
subcortical coherencies during movement and support a role
for striatal dopamine in uncoupling cortical and subcortical
networks.
Finally, we also measured subcortical cross hemispheric
coupling during movement (i.e., CohSTN−/STN+, Figure 2).
In line with previous measurements at rest (de Solages et al.,
2010; Kato et al., 2015), we showed a subject-specific Coh
in the beta-range between the two STNs (Figure 2). Of
relevance, such subcortical cross hemispheric coherence was
not modulated by movements, despite the differences in
beta-power between STN+ and STN− (Figure 1A), and it
did not mirror the movement-related drop of the cortical-
subcortical coherence (Figure 2). Our findings are consistent
with recent studies, though with different tasks, showing a
lack of modulation of subcortical cross-hemispheric coupling in
the beta-band during movements in subjects with PD (Darvas
and Hebb, 2014; Kato et al., 2016). We speculate that such
a persistent subcortical coherence might not be related to
motor processing but relies upon a (bilateral) dopaminergic
loss.
Our study has several limitations, in particular the small
sample size, although in the range of previous reports
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FIGURE 2 | Coherence analyses. Subcortical- (i.e., CohSTN−/STN+) and cortical-subcortical coherence (i.e., CohSTN−/MC−, CohSTN−/MC+ and CohSTN+/MC−,
CohSTN+/MC+) are reported for each subject with respect to STN− and STN+. White color shows lack of coherence. From blue to red color we show increasing
significant coherence between brain structures. Results were mirrored by iCoh, thus supporting the lack of volume conduction artifact (Supplementary Material,
Results, Figure S8). As in Figure 1, the super-imposed vertical dotted line at 0 s shows the RT. We also indicated, with a dotted line at −1.7 s, the mean OT of all
trials (see also Figure S1) as a rough indication of movement OT. “IPSI” and “CONTRA” refer to movement performed with the hand ipsilateral or contralateral to the
examined STN (STN− or STN+). “−” (MC− and STN−) and “+” (MC+ and STN+) refer instead to the side with less and more striatal dopaminergic innervation or the
more and less clinically affected hemibody (for wue05). MC, motor cortex; STN, subthalamic nucleus. MC, motor cortex; STN, subthalamic nucleus.
(Cassidy et al., 2002; Priori et al., 2002; Alegre et al., 2005).
The exiguous number of patients able to complete the study
protocol did not allow defining whether the role of striatal
dopamine deteriorates linearly or step-wise along with disease
progression. Furthermore, we were not able to disentangle
the effect of an unbalanced dopaminergic activity between the
two hemispheres. It is worth noting that all patients showed
a bilateral dopaminergic loss (Table 1). Besides the extent
of dopaminergic striatal innervation per se, it is tempting to
speculate that the asymmetry of this denervation might also
play a role in the cortical-subcortical processing of motor
commands.
Another limitation of this study is the focus on beta band
modulation. This choice was based on available data suggesting
that excessive beta-activity is either related to or causing
bradykinesia in PD (Hammond et al., 2007; Eusebio and Brown,
2009; Brittain and Brown, 2014). Moreover, it was also shown
that movement-related cortical-subcortical modulation happens
specifically in the beta frequency band (Lalo et al., 2008; see also
Figure 1 and Supplementary Figure S5).
Despite these limitations, it is worth mentioning that in this
study the LFPs of STN were recorded months after surgery by
means of a new, fully implantable device. Delayed recordings
decrease the influence of high impedance variability and of
microlesioning effect, which influence immediate post-operative
recordings (Lalo et al., 2008).
Our conclusions are presumptive, but support the
notion of a dopaminergic role in shielding subcortical
structures from an excessive cortical entrapment and
cross hemispheric coupling, thus allowing fine tuning of
movement (Hammond et al., 2007). Furthermore, in patients
with PD an unbalanced modulation of motor processing
between the two hemispheres, which reflect the degree of
dopamine loss and the lateralization of clinical symptoms,
might have relevant therapeutic implications. The success of
adaptive or patterned stimulation protocols should also take
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into account dopamine-dependent STN neuronal activity
to offer more symptom-targeted stimulation effects than
conventional DBS.
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